Helptext

Movies



Company Information

Company NameSenzime AB
Company Idea

Senzime develops unique patient-oriented monitoring systems that make it possible to assess patients' biochemical and physiological processes before, during and after surgery. The portfolio of technologies includes bedside systems that enable automated and continuous monitoring of life-critical substances such as glucose and lactate in both blood and tissues, as well as systems to monitor patients' neuromuscular function perioperatively and in the intensive care medicine setting. The solutions are designed to ensure maximum patient benefit, reduce complications associated with surgery and anesthesia, and decrease health care costs. Senzime operates in growing markets that in Europe and the United States are valued in excess of SEK 10 billion. The company's shares are listed on AktieTorget (ATORG: SEZI) www.senzime.com

Phone018-51 56 40CEOLena Söderström
E-mailinfo(snabel-a)senzime(punkt)comChairm. of the BoardPhilip Siberg
Homepagehttp://www.senzime.com 

Instrument Information

Full NameSenzime BTAShort NameSEZI BTA
No of sharesPar Value0.0 SEK
TypePaid subscription shareISIN codeSE0009696446
InfoHandlas från den 14 mars 2017 till dess att emissionen är registrerad hos Bolagsverket.

Price Information

+/-
%
Latest0.00
High0.00
Low0.00
Volume0
Turnover (SEK)0.00
Market Cap (MSEK)

Orders

VolumeBidAskVolume

Deals

TimeBuyerSellerPriceVolume

Scheduled Reports

DateReport
2017-05-23Delårsrapport ett
2017-05-23Årsstämma
2017-08-31Halvårsrapport
2017-11-28Delårsrapport tre




  • Mäster Samuelsgatan 42
  • 111 57 Stockholm
  • Telefon: 08 - 511 68 000
  • info(snabel-a)aktietorget(punkt)se